Table 2.
Composition of the non-ionic polymer formulations (PF). The ratios represent percentage weight to volume (w/v).
| PF1 (B4) | PF2 | PF3 | PF4 | PF5 | PF6 | PF7 | PF8 | PF9 | PF10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| NAC | 1% | |||||||||
| DPG | 10 mL | |||||||||
| P188® | 1% | |||||||||
| P407® | 1% | |||||||||
| PEG 6000 | 1% | |||||||||
| IR® | 1% | |||||||||
| K12® | 1% | |||||||||
| PVA/VA S630 | 1% | |||||||||
| TPGS | 1% | |||||||||
| HS 15® | 1% | |||||||||
| Soluplus® | 1% | |||||||||
Polyoxyethylene (1 6 0) and polyoxypropylene (30) glycol (Kolliphor® P188), polyoxyethylene (1 9 6) and polyoxypropylene (67) glycol (Kolliphor® P407), PEG 6000, polyvinyl alcohol-polyethylene glycol graft copolymer (Kollicoat® IR), polyvinylpyrrolidone (Kollidon® K12), 60:40 linear random copolymer of N-vinyl-2-pyrrolidone and vinyl acetate (PVP/VA S-630), D-α-tocopherol polyethylene glycol 1000 succinate (TPGS), macrogol 15 hydroxystearate (Kolliphor® HS 15), polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (Soluplus®), Niacinamide (NAC), dipropylene glycol (DPG).